Natural Product: NPC543409

Natural Product IDNPC543409
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
3-hydroxy-4-(1H-indol-3-yl)butan-2-one
IUPAC Name 3-hydroxy-4-(1~{H}-indol-3-yl)butan-2-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HRSIDIKGNJOTMN-UHFFFAOYSA-N
Standard InCHI InChI=1S/C12H13NO2/c1-8(14)12(15)6-9-7-13-11-5-3-2-4-10(9)11/h2-5,7,12-13,15H,6H2,1H3
SMILES CC(=O)C(O)CC1=CNC2=CC=CC=C12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   203.09 Volume:   214.39
?
Van der Waals volume.
Dense:   0.947 LogP:   1.822
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.716
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.322
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   11.0
TPSA:   53.09
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   2.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.797 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.577 Fsp3:   0.25
MCE-18:   22.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.169 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.056
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.096
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.176 Promiscuous compounds:   0.274

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.129 MDCK Permeability:   -4.63
Pgp-inhibitor:   0.013 Pgp-substrate:   0.482
PAMPA:   0.62
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.017 30% Bioavailability (F30%):   0.11
50% Bioavailability (F50%):   0.872

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.445 MRP1:   0.621
Plasma Protein Binding (PPB):   65.997% Volume Distribution (VD):   0.095
Fu: 34.779%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.629
OATP1B3 inhibitor:   0.979 BCRP inhibitor:   0.228
BSEP inhibitor:   0.584

ADMET: Metabolism

CYP1A2-inhibitor:   0.007 CYP1A2-substrate:   0.641
CYP2C19-inhibitor:   0.004 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.031 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.263 CYP2D6-substrate:   0.049
CYP3A4-inhibitor:   0.103 CYP3A4-substrate:   0.003
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.538
HLM stability:   0.96
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  10.199 Half-life (T1/2):  1.621

ADMET: Toxicity

hERG Blockers:  0.078 hERG Blockers (10um):  0.411
Human Hepatotoxicity (H-HT):  0.531 Drug-induced Liver Injury (DILI):  0.224
AMES Toxicity:  0.491 Rat Oral Acute Toxicity:  0.361
Maximum Recommended Daily Dose:  0.527 Skin Sensitization:  0.126
Carcinogencity:  0.514 Eye Corrosion:  0.015
Eye Irritation:  0.828 Respiratory Toxicity:  0.635
Drug-induced Neurotoxicity:  0.529 Ototoxicity:  0.616
Hematotoxicity:  0.302 Drug-induced Nephrotoxicity:  0.354
Genotoxicity:  0.734 RPMI-8226 Immunitoxicity:  0.023
A549 Cytotoxicity:  0.04 Hek293 Cytotoxicity:  0.095
BCF:   0.303
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.922
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.272
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.461
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO62724 Actinopolymorpha rutilus Genus Actinopolymorphaceae Bacteria n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC543409 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8409 Intermediate Similarity NPC480551
0.7872 Intermediate Similarity NPC480550
0.6364 Remote Similarity NPC230869
0.6275 Remote Similarity NPC469358
0.619 Remote Similarity NPC601214
0.6 Remote Similarity NPC279081
0.587 Remote Similarity NPC29886
0.587 Remote Similarity NPC72435
0.5849 Remote Similarity NPC480549
0.5833 Remote Similarity NPC310665
0.58 Remote Similarity NPC315555
0.5778 Remote Similarity NPC96102
0.5769 Remote Similarity NPC609424
0.566 Remote Similarity NPC200214
0.5614 Remote Similarity NPC606619
0.5614 Remote Similarity NPC610347
0.56 Remote Similarity NPC267343
0.551 Remote Similarity NPC605863
0.549 Remote Similarity NPC55772
0.549 Remote Similarity NPC600736
0.5424 Remote Similarity NPC603162
0.5417 Remote Similarity NPC84911
0.5417 Remote Similarity NPC154339
0.54 Remote Similarity NPC603879
0.5385 Remote Similarity NPC190296
0.537 Remote Similarity NPC608269
0.5333 Remote Similarity NPC102423
0.5333 Remote Similarity NPC300149
0.5333 Remote Similarity NPC42372
0.5306 Remote Similarity NPC73767
0.5294 Remote Similarity NPC78020
0.5283 Remote Similarity NPC489200
0.5283 Remote Similarity NPC480318
0.5263 Remote Similarity NPC480548
0.5263 Remote Similarity NPC609408
0.5192 Remote Similarity NPC59269
0.5179 Remote Similarity NPC602670
0.5094 Remote Similarity NPC149155
0.5094 Remote Similarity NPC203468
0.5094 Remote Similarity NPC110500
0.5094 Remote Similarity NPC605329
0.5085 Remote Similarity NPC11126
0.5085 Remote Similarity NPC71037
0.5085 Remote Similarity NPC605381
0.5079 Remote Similarity NPC481141
0.5079 Remote Similarity NPC606618

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC543409 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5778 Remote Similarity NPD198 Clinical (unspecified phase)
0.551 Remote Similarity NPD786 Pre-clinical
0.5283 Remote Similarity NPD749 Clinical (unspecified phase)
0.5094 Remote Similarity NPD482 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data